Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,088 | 166 | 96.0% |
| Education | $129.33 | 5 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $548.16 | 23 | $0 (2018) |
| Astellas Pharma US Inc | $303.28 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $275.34 | 19 | $0 (2017) |
| Celgene Corporation | $189.38 | 8 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $174.37 | 14 | $0 (2017) |
| Amgen Inc. | $168.59 | 9 | $0 (2018) |
| Sirtex Medical Inc | $162.01 | 3 | $0 (2017) |
| Genentech USA, Inc. | $157.49 | 12 | $0 (2017) |
| Pharmacyclics LLC, An AbbVie Company | $154.88 | 3 | $0 (2017) |
| PFIZER INC. | $130.80 | 10 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $94.00 | 1 | Astellas Pharma US Inc ($94.00) |
| 2018 | $216.67 | 8 | E.R. Squibb & Sons, L.L.C. ($111.39) |
| 2017 | $2,907 | 162 | E.R. Squibb & Sons, L.L.C. ($436.77) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/07/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.00 | General |
| 03/28/2018 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug), MUGARD | Education | In-kind items and services | $12.21 | General |
| Category: PARENTERAL IRON REPLACEMENT | ||||||
| 02/26/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
| 02/19/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $98.28 | General |
| Category: Oncology | ||||||
| 02/15/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| Category: Oncology | ||||||
| 01/24/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Oncology | ||||||
| 01/22/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Oncology | ||||||
| 12/22/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.16 | General |
| Category: Oncology | ||||||
| 12/21/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.89 | General |
| Category: Oncology | ||||||
| 12/14/2017 | Ipsen Biopharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $28.23 | General |
| 12/13/2017 | TerSera Therapeutics LLC | ZOLADEX (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2017 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2017 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Oncology | ||||||
| 12/08/2017 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Oncology | ||||||
| 12/06/2017 | Genentech USA, Inc. | GAZYVA (Biological) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: BioOncology | ||||||
| 12/05/2017 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Oncology | ||||||
| 12/01/2017 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Oncology | ||||||
| 11/30/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ONCOLOGY | ||||||
| 11/28/2017 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: BioOncology | ||||||
| 11/27/2017 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2017 | Amgen Inc. | Nplate (Biological), Prolia, XGEVA | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Hematology | ||||||
| 11/16/2017 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: HEMATOLOGY | ||||||
About Dr. Robert Kessler, MD
Dr. Robert Kessler, MD is a Hematology & Oncology healthcare provider based in Marrero, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013972348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Kessler, MD has received a total of $3,217 in payments from pharmaceutical and medical device companies, with $94.00 received in 2019. These payments were reported across 171 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,088).
Practice Information
- Specialty Hematology & Oncology
- Location Marrero, LA
- Active Since 04/19/2006
- Last Updated 01/17/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1013972348
Products in Payments
- OPDIVO (Biological) $409.61
- Xtandi (Drug) $173.62
- SIR-Spheres Microspheres (Device) $162.01
- Imbruvica (Drug) $154.88
- KEYTRUDA (Biological) $137.41
- XTANDI (Drug) $136.20
- EMPLICITI (Biological) $113.84
- Revlimid (Drug) $96.50
- NINLARO (Drug) $89.02
- Xofigo (Drug) $81.18
- TASIGNA (Drug) $75.74
- IBRANCE (Drug) $72.39
- Neulasta (Biological) $58.26
- JADENU (Drug) $56.86
- CYRAMZA (Drug) $56.66
- KISQALI (Drug) $53.27
- AFINITOR (Drug) $48.82
- Perjeta (Biological) $46.61
- SUBSYS (Drug) $43.86
- Kyprolis (Biological) $41.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.